Bicavera 1.5% Glucose 1.75 Mmol/L Calcium Solution For Peritoneal Dialysis

0875216_01_K001.qxp:0875216    02.07.2014    12:36 Uhr Seite 5

0875216_01_K001.qxp:0875216    02.07.2014    12:36 Uhr Seite 5

bica Vera

1.5% Glucose,

1.75 mmol/l Calcium

Package leaflet:

Information for the user

bicaVera 1.5% Glucose, 1.75 mmol/l Calcium, Solution for peritoneal dialysis

What is in this leaflet:

1.    What bicaKera is and what it is used for

2.    What you need to know before you use bicaKera

3.    How to use bicaKera

4.    Possible side effects

5.    How to store bicaKera

6.    Contents of the pack and other information

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

•    Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor, pharmacist or nurse.

•    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

•    If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

IWhat bicaVera is and what it is ■ used for

bicaVera is used for cleaning the blood via the

peritoneum in patients with end-stage chronic kidney failure. This type of blood cleaning is called peritoneal dialysis.

2 What you need to know before ■ you use bicaVera

Do not use bicaVera 1.5% Glucose,

1.75 mmol/l Calcium

•    if the level of potassium in your blood is very low

•    if the level of calcium in your blood is very high

Peritoneal dialysis treatment must not be started if you have

•    alterations in the abdominal region such as

-    injuries, or after surgery

-    severe burns

-    large, inflammatory skin reactions

-    inflammation of the peritoneum

-    non-healing, weeping wounds

-    umbilical, inguinal or diaphragmatic hernias

-    ulcers

•    inflammatory bowel diseases

•    intestinal obstruction

•    lung diseases, particularly pneumonia

•    blood poisoning caused by bacteria

•    extremely high levels of fat in the blood

•    poisoning due to urine products in the blood which cannot be treated by blood cleaning

•    severe malnutrition and loss of weight, particularly if adequate intake of food containing proteins is not possible.

Warnings and precautions

Inform your doctor immediately

•    if you have a severe loss of electrolytes (salts)

due to vomiting and/or diarrhoea

•    if you have an inflammation of the peritoneum,

recognisable by a cloudy dialysate, abdominal pain, fever, feeling unwell or in very rare cases blood poisoning. Please show the bag containing the drained dialysate to your doctor.

Blood cleaning can lead to a loss of proteins and water-soluble vitamins. An adequate diet or nutritional supplements are recommended in order to avoid deficiency states.

Your doctor will check your electrolyte (salt) balance, blood cell counts, kidney function, bodyweight and nutritional state.

Other medicines and bicaVera

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Because blood cleaning may influence the effects of medicines, your doctor may need to change their dosages, especially those of

   Medicines for heart failure, such as digitoxin.

Your doctor will check the level of potassium in your blood and, if necessary, will take appropriate measures.

   Medicines that influence calcium levels such as those containing calcium or vitamin D.

   Medicines that increase the excretion of urine

such as hydrochlorothiazide.

   Medicines taken by mouth that lower blood sugar levels or insulin. Your blood sugar level should be measured regularly.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

There are no adequate data from the use of bicaKera in pregnant women or during lactation period. If you are pregnant or breast-feeding you should use bicaKera only if your doctor considers this absolutely necessary.

Driving and using machines

When used as prescribed bicaKera does not impair your ability to drive or operate machines.

How to use bicaVera

1 2

Automatic peritoneal dialysis (APD):

Bag exchange is controlled automatically by the machine over night. For this the bicaKera sleep^safe system is used.

Use bicaKera in the peritoneal cavity only.

Use bicaKera only if the solution is clear and the bag is undamaged.

bicaKera is available in a double-chamber bag. Before use the solutions in the two chambers must be mixed as described.

Handling instructions

staysafe® system for continuous ambulatory peritoneal dialysis (CAPD):

The solution bag is first warmed to body temperature. This should be done by using an appropriate heater tray. The heating time for a 2000 ml bag with a starting temperature of 22°C is approximately 120 min.

More detailed information can be obtained from the operating instructions of the bag warmer. A microwave oven must not be used to warm the solution due to the risk of local overheating. After warming the solution you can start with the exchange of the bags.

1. Preparation of the solution

t Place the bag on a solid surface. t Open the overwrap of the bag and seal of the disinfection cap. t Check the solution bag before use (label, expiry date, clearness of the solution, integrity of the bag). t Wash your hands with an antimicrobial washing lotion. t Roll up the bag from one of the upper ends until the middle seam opens. The solutions in the two chambers are mixed automatically. t Then roll up the bag from the upper edge, until the peel seam of the lower triangle is completely opened. t The ready-to-use solution should be used immediately, but within a maximum of 24 hours after mixing!

2. Preparation of the bag exchange

t Hang the solution bag on the upper hook of the infusion pole, unroll the tubing line of the solution bag, and place the DISC into the organizer. After unrolling the tubing line to the drainage bag, hang the drainage bag on the lower hook of the infusion pole and place the disinfection cap into the organizer. t Place catheter adapter into the organizer. t Disinfect your hands and remove the protection cap of the DISC. t Connect catheter adapter to the DISC.

3. Outflow

t Open the catheter clamp. The outflow starts. t Position •


Glucose monohydrate (equivalent to 15.0 g glucose)

16.5 g

Sodium chloride

5.786 g

Sodium hydrogen carbonate

2.940 g

Calcium chloride dihydrate

0.2573 g

Magnesium chloride hexahydrate

0.1017 g



4 x 1500 ml bags 4 x 2000 ml bags 4 x 2500 ml bags 4 x 3000 ml bags

4 x 1500 ml bags 4 x 2000 ml bags 4 x 2500 ml bags 4 x 3000 ml bags

Not all pack sizes may be marketed.

4.    Flush

t Flush the drainage bag with fresh solution (approximately 5 seconds). t Position ••

5.    Inflow

t Connect the solution bag with the catheter. t Position 0<J#

6.    Security step

t Close the catheter adapter by putting in the PIN. t Position ••••

7.    Disconnection

t Remove the catheter adapter from the DISC and screw the new disinfection cap to the catheter adapter.

8.    Closure of the DISC

t Close the DISC with the open end of the protection cap of the used disinfection cap, which is placed in the right hole of the organizer.

9.    Check the drained dialysate and dispose of it.

sleep2safe system for automatic peritoneal dialysis (APD):

During automatic peritoneal dialysis (APD) the solution is warmed automatically in the machine.

1. Preparation of the solution

see instructions on the staysafe® system above

2.    Unroll tubing of bag.

3.    Remove the protection cap.

4.    Insert connector in free sleepsafe tray port.

5.    The bag is now ready for use with the sleep^safe set.

Each bag should be used only once and any unused solution remaining must be discarded.

After appropriate training, bicaVera can be used independently at home. Ensure that you follow all the procedures you learnt during training and maintain hygienic conditions when exchanging bags.

Always check the drained dialysate for cloudiness. See section 2. “Warnings and precautions".

If you use more bicaVera than you should

If you allow too much solution to flow into the peritoneal cavity, the excess can be drained off. If you use too many bags please contact your doctor as this can result in fluid and/or electrolyte imbalances.

If you forget to use bicaVera

Try to attain the volume of dialysate prescribed for each 24-hour period in order to avoid the risk of possibly life-threatening consequences. You should check with your doctor if you are not sure.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects may occur as a result of the treatment:

•    inflammation of the peritoneum with signs of cloudiness of the drained dialysate, abdominal pain, fever, feeling unwell or in very rare cases blood poisoning.

Please show the bag containing the drained dialysate to your doctor.

•    inflammation of the skin at the catheter exit site or along the length of the catheter, recognisable by redness, swelling, pain, weeping or crusts.

•    hernia of the abdominal wall.

Please contact your doctor immediately if you notice any of these side effects.

Other side effects of the treatment are:

•    problems with inflow or outflow of the dialysate

•    diarrhoea

•    constipation

•    breathing difficulties

•    sensation of stretching or fullness of the abdomen

•    shoulder pain.

The following side effects may occur when bicaVera is used:

•    potassium deficiency

•    calcium excess if the calcium intake is too high

•    body fluid levels too low, which can be recognised by rapid weight loss, low blood pressure, rapid pulse

•    body fluid levels too high, which can be recognised by water in the tissues and lung, high blood pressure, breathing difficulties

•    high blood sugar levels

•    high blood fat levels

•    weight gain.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:

Yellow Card Scheme Website: By reporting side effects you can help provide more information on the safety of this medicine.

How to store bicaVera

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the bag and carton.

Do not store bicaVera below 4 °C.

6 Contents of the pack and other ■ information

What bicaVera contains

The active substances in one litre of the ready-to-use solution are:

These quantities of active substances are equivalent to: 83.25 mmol/l glucose, 134 mmol/l sodium,

1.75 mmol/l calcium, 0.5 mmol/l magnesium,

104.5 mmol/l chloride and 34 mmol/l hydrogen carbonate.

The other ingredients of bicaVera are water for injections, hydrochloric acid, sodium hydroxide, carbon dioxide.

What bicaVera looks like and contents of the pack

bicaVera is a solution for peritoneal dialysis. The solution is clear and colourless.

The theoretical osmolarity of the ready-to-use solution is 358 mOsm/l, the pH is about 7.40. bicaVera is available in a double-chamber bag. One chamber contains the alkaline sodium hydrogen carbonate solution and the other the acidic glucose-based electrolyte solution in a ratio of 1:1.

bicaVera is available in the following application systems and pack sizes per carton:

Marketing Authorisation Holder

Fresenius Medical Care Deutschland GmbH,

61346 Bad Homburg v.d.H., Germany


Fresenius Medical Care Deutschland GmbH, Frankfurter StraBe 6-8, 66606 St. Wendel, Germany

Distributed in the UK by

Fresenius Medical Care (UK) Ltd, Nunn Brook Road, Huthwaite, Nottinghamshire, NG17 2HU

This medicinal product is authorised in the Member States of the EEA under the following names:

See end of this multilingual package leaflet.

This leaflet was last revised in 06/2014


The ready-to-use solution should be used immediately, but within a maximum of 24 hours after mixing.

Do not use this medicine if you notice that the solution is not clear or the bag is damaged.



Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Your doctor will determine the method, duration and frequency of use and the required volume of solution and retention time in the peritoneal cavity.

If tension in the abdominal region occurs the volume must be reduced.

Continuous ambulatory peritoneal dialysis (CAPD):

   Adults: the usual dose is 2000-2500 ml solution four times daily depending on bodyweight and kidney function.

Bags are exchanged over 24 hours. After 2-10 hours retention time the solution is drained off.


   Children up to 18 years of age: The doctor will determine the volume of dialysis solution required depending on the age, height and bodyweight of the child.

The recommended dose is 30-40 ml/kg bodyweight.